{"contentid": 488673, "importid": NaN, "name": "Global life sciences industry calls for action on vaccine access", "introduction": "Trade bodies representing the global life sciences industry have come together to urge coordinated steps to improve access to coronavirus vaccines.", "content": "<p>Trade bodies representing the global life sciences industry have come together to urge coordinated steps to improve access to coronavirus vaccines.</p>\n<p>In a statement, the groups said: &ldquo;Immediate action must focus on stepping up responsible dose sharing and maximizing production without compromising quality or safety.&rdquo;</p>\n<p>The call to action has been issued by leading European trade group The European Federation of Pharmaceutical Industries and Associations (EFPIA) and the USA&rsquo;s Pharmaceutical Research and Manufacturers of America (PhRMA), as well as several other national and regional bodies.</p>\n<p>There has been an increased level of concern over the availability of vaccines in lower-income countries, as rich countries move on to vaccinating ever younger and healthier parts of their populations.</p>\n<p>Concerns have been made more acute by the evolution of new variants which analysts worry could potentially undermine the protection afforded by existing vaccines.</p>\n<p>Globally, new infections have begun to fall from an early-May peak of around 900,000 per day but remain high, with an estimated 681,000 new cases on May 15.</p>\n<p>Since the beginning of the pandemic, there have been around 164 million cases of coronavirus, with an estimated 3.5 million deaths.</p>\n<h2>Steps to broaden access</h2>\n<p>The global life sciences industry has called on manufacturers, governments, and non-governmental organizations to work together to broaden access to vaccines, with a number of recommendations to improve the situation.</p>\n<p>Innovative vaccine manufacturers and biotech companies are being asked to increase dose sharing through COVAX or other efficient mechanisms, and to &ldquo;expend every effort&rdquo; to make additional uncommitted COVID-19 vaccine doses available.</p>\n<p>They are also being called upon to undertake all practicable efforts to maximize COVID-19 vaccine output, and to eliminate trade barriers, supporting the Coalition for Epidemic Preparedness Innovations' (CEPI's) efforts to create an independent platform for matchmaking and fill and finish capacity.</p>\n<p>In addition, the trade bodies have called on manufacturers to support country readiness by partnering with governments, and drive further innovation by prioritizing the development of new COVID-19 vaccines.</p>", "date": "2021-05-19 12:23:00", "meta_title": NaN, "meta_keywords": "access, vaccines, life, industry, sciences, global, trade, bodies, action, vaccine, steps, coronavirus, improve, manufacturers, calls, coordinated, urge", "meta_description": "Trade bodies representing the global life sciences industry have come together to urge coordinated steps to improve access to coronavirus vaccines.", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 1, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-05-19 12:23:05", "updated": "2021-05-19 12:43:35", "access": NaN, "url": "https://www.thepharmaletter.com/article/global-life-sciences-industry-calls-for-action-on-vaccine-access", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "novavax_vaccine_large.jpg", "image2id": "novavax_vaccine_small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Biotechnology", "therapy area_tag": "Infectious diseases, Vaccines", "topic_tag": "Coronavirus, Focus On, Pricing, reimbursement and access, Production, Public health", "geography_tag": "Global", "company_tag": "ABPI, EFPIA, PhRMA", "drug_tag": "Comirnaty, mRNA-1273, Vaxzevria", "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-05-19 12:23:00"}